Oxadiazoles are heterocyclic compounds that have a remarkable range of applications. This overview focused on investigating the potential and scientific and technological evolution of these compounds through an analysis of patent databases and scientific papers. Prospecting technology using patent databases is an important tool for mapping technologies or technological areas, allowing the identification of such things as trends and investments. The mapping of 1,2,4-oxadiazoles patents and patent applications was facilitated by using different key word from scientific papers found in the INPI, Esp@cenet, WIPO, LATIPAT databases and in the Web of Science TM database. The majority of the patent records related to the researched technology had been filed in the Esp@cenet database. A constant linear growth in the number of records of patents granted could be observed over the years, with a remarkable dominance of patents recorded in the USA (24.7%). In addition, when the search through scientific papers was performed, the USA was also the country that had produced the largest number of publications. On the other hand, Brazil presented only two patent grant records (0.2%) and fifty-four published papers related to the technology being researched. In summary, there is great scientific and technological interest in the 1,2,4-oxadiazoles.
Este texto pretende investigar o efeito contingente de tratamento decorrente da experiência de escrita. Para isso, articulamos conceitos extraídos de textos da teoria da literatura, da filosofia e da psicanálise, que se propõem analisar a experiência de escrita e seus efeitos para o sujeito que escreve.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.